SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is drawing attention amid a selloff in AI infrastructure stocks and concerns that its heavy debt load and costly financing could constrain growth. Traders are split between warnings about dilution and default risk and bullish arguments about AI-compute demand, with Goldmans upgrade and ARKs purchases cited as counterpoints that have not settled the debate.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO selloff is dominating discussion, with traders citing successive share unlocks and insider selling, a TD Cowen price-target cut, and concerns about OpenAI customer concentration and the companys ability to scale. Sentiment is largely bearish, though some investors view the decline as oversold and are averaging down.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is caught in a semiconductor selloff as traders question the returns and financing behind AI infrastructure spending, with CEO Hock Tans warning that some AI investing resembles gambling adding to concerns. Bears see his comments and AI-credit risks as reasons for continued weakness, while bulls argue demand and Broadcoms fundamentals remain intact and view the decline as a buying opportunity.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is drawing attention as the S&P 500 rebounds after a tech-led selloff, with investors watching upcoming major-company earnings for signs the recovery can hold. Traders are split between viewing the move as a relief bounce and expecting further downside, amid concerns about AI spending and debt, oil prices, and weak market breadth.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is drawing attention over concerns that its debt-funded AI data-center expansion, heavy capital spending and weak free cash flow could strain its credit profile, amid broader doubts about AI infrastructure financing and demand. Many traders remain bearish after the selloff, while others argue Oracles cloud business and backlog can eventually generate returns; speculation about financing arrangements and an upcoming investor event also appears.

Silicon Motion Technology Corp. engages in the development, manufacture, and supply of semiconductor products for the electronics market. The firm’s products include Flash Controllers, Storage Solutions, and others. It offers embedded and expandable storage, radio frequency integrated circuits, and embedded graphics. The company was founded by Wallace C. Kou in November 1995 and is headquartered in Hong Kong.

Silicon Motion Technology Corp - ADR

Silicon Motion Technology Corp.

SIMO is drawing attention for its growth in AI and data-center storage, particularly boot-drive shipments and MonTitan enterprise SSD controllers, alongside strong results and an upbeat outlook. Many traders see room for further growth, while others point to sharp share-price swings, technical weakness and dilution concerns tied to convertible notes.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealths third-quarter earnings beat and raised full-year outlook, supported by improved medical-cost control, are driving attention. Traders are split between viewing the results as evidence of a turnaround and questioning whether the margin improvement will last, while many reacted to the stocks volatile, initially muted response to the report.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention after a steep AI-infrastructure selloff tied to concerns about neocloud financing, debt, and whether massive data-center spending will earn adequate returns, followed by a volatile rebound. Traders are split between viewing the decline as an oversold buying opportunityoften arguing NBIS is better positioned than CoreWeaveand expecting rallies to fade as sector and market uncertainty persists.

Aventus Network

AVT is drawing attention as traders watch a volatile, thinly traded rebound for a breakout, focusing on trading volume and resistance levels. Aventus Clouds decentralized-compute and enterprise-appchain updates provide a bullish project narrative, but traders remain divided over whether momentum can persist amid low liquidity and selling pressure.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led relief rally after a sharp AI-related selloff has put QQQ in focus, with traders debating whether the volatile rebound signals recovery or is a temporary bounce. Upcoming megacap earnings are a key test, while concerns about AI infrastructure spending and weak market breadth sustain bearish views.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure  

Equity

Growth prospects, business challenges, legal changes, and rising competition from SpaceX shaped Wall Street activity this week.

Wall Street’s Next Movers

The market is serving up a powerful mix of movers, including Alaunos Therapeutics (NASDAQ:TCRT) completed a major acquisition backed by a $350 million private placement, while NeOnc Technologies Holdings (NASDAQ:NTHI) is preparing for an important FDA discussion. Verastem Oncology (NASDAQ:VSTM) reported fresh cancer-drug results alongside a major financing and leadership transition, and Liquidia (NASDAQ:LQDA) resolved a prolonged legal battle over its pulmonary-hypertension treatment. Bending Spoons (NASDAQ:BSP) is attracting another major investment from Berkshire Hathaway.

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Liquidia settles six legal disputes with United Therapeutics, securing Yutrepia access for PAH patients but facing $380.7 million in payments and a narrower drug label.

LQDA Stock Rockets 40% Today – BTIG Calls United Therapeutics Settlement ‘Better Than Best-Case Scenario’

LifeSci Capital said the agreement removes a major obstacle that could have discouraged potential buyers from pursuing an acquisition of Liquidia.


Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday

U.S. stocks mostly fell, but Bending Spoons surged 40% after Berkshire's $330M investment. Liquidia and Verastem also posted strong gains.read more...

Dow Futures Rise, Nasdaq Subdued Premarket Ahead Of Inflation Data: ASML, MU, SKHY, TSLA, BAC, LQDA, GME, IREN Stocks In Focus

On Stocktwits, retail sentiment toward SPY and QQQ has remained ‘bullish’ ahead of the CPI print. 


Liquidia Corporation Stock Is Trending In After-Hours Following United Therapeutics Settlement: What You Should Know

Liquidia shares surged 42.48% in after-hours trading after settling all pending litigation with United Therapeutics over YUTREPIA patents.read more...

LQDA Explodes After Hours On Deal Ending Years Of Patent Fight, Keeping YUTREPIA On Market 

The agreement resolves all six ongoing lawsuits between Liquidia, United Therapeutics and related parties.


LIQUIDIA CORPORATION LQDA INVESTORS: Contact Kirby McInerney LLP About the Firms Securities Investigation Following 57.2% Share Drop

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Liquidia Corporation (Liquidia or the Company) (NASDAQ: LQDA) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws or other unlawful...

Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky

Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & KorsinskyPR NewswireNEW YORK, Oct. 12, 2026Liquidia shareholders took a roughly 57% loss after a court found that Yutrepia infringed two valid United...

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Crocs stock rose 8.5% this week as Barclays upgraded it to ‘Overweight’ from ‘Equal Weight’.</li><li>Liquidia stock surged 27% this week, its strongest since May, after settling six lawsuits with United Therapeutics.&nbsp;</li><li>Albertsons faced downgrades after its Q2 results, as concerns grew over operational hurdles.&nbsp;</li></ul><p>Wall Street analysts warmed to Crocs Inc. (CROX) and Liquidia Corp. (LQDA) on growth potential and easing legal risks, while Albertsons Companies (ACI) faced downgrades from three firms. Meanwhile, SpaceX’s growing ambitions rattled sentiment around AT&amp;T (T) and AST SpaceMobile (ASTS), triggering concerns over telecom competition and satellite launch plans.&nbsp;</p><h2 class="st-heading-2">Product Momentum Supports Crocs Upgrade</h2><p><a href="https://stocktwits.com/symbol/CROX">Crocs stock</a> gained 8.5% this week as the company received an upgrade to ‘Overweight’ from ‘Equal Weight’ at Barclays, which increased its price target to $139 from $118. The firm sees a clearer route to expansion over the coming years.</p><p>Barclays believes improving conditions across the business could help Crocs move past a period of uneven performance. Although its North American operations continue to face short-term challenges, investments in new products, additional categories, and brand development appear to be supporting demand. International operations are already generating sales growth.</p><p>Last month, Crocs CFO Patraic Reagan said footwear demand naturally rises and falls every few years, but Crocs is reducing its reliance on classic clogs by expanding into sandals, ballet flats, recovery shoes and other styles. Its sandal business generates nearly $500 million annually. The company is also expanding HEYDUDE into products for activities like boating, fishing and work.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261016_043744873_5d87402f2b.png" alt="koyfin_20261016_043744873.png" width="2400" height="1240"></figure><h2 class="st-heading-2">Legal Settlement Lifts Liquidia Outlook</h2><p><a href="https://stocktwits.com/symbol/LQDA">Liquidia stock</a> has climbed 27% and is on track for its best week since May after it won upgrades from LifeSci Capital and BTIG after reaching an agreement with United Therapeutics Corp. (UTHR) that resolves six outstanding lawsuits between the companies.</p><p>LifeSci Capital analyst Gaurav Maini raised Liquidia to ‘Outperform’ from ‘Market Perform’ and established a $59 price target. The firm believes the agreement removes a major source of uncertainty, allowing Yutrepia to remain available for pulmonary arterial hypertension while removing its use for pulmonary hypertension associated with interstitial lung disease from the label. The settlement could also make Liquidia more attractive to potential strategic partners or buyers.</p><p>Separately, BTIG moved to ‘Buy’ from ‘Neutral’ and set a $70 target. The firm viewed the settlement terms more positively than it had expected before the announcement.</p><h2 class="st-heading-2">Array Technologies Draws Contrarian Interest</h2><p><a href="https://stocktwits.com/symbol/ARRY">Array Technologies stock</a> was upgraded to ‘Outperform’ from ‘Neutral’ by Mizuho, even as the firm cut its price target to $5 from $7. The stock has dropped 61% this year, but the analyst sees room for gains compared with the risk of further losses.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261016_044341010_b622791540.png" alt="koyfin_20261016_044341010.png" width="2400" height="1240"></figure><p>Mizuho believes investors are too worried about weaker demand and the company’s need for cash. The firm expects business to improve in 2027, supported by existing orders and acquisitions that could help cut costs and improve efficiency. It also expects sales and profit margins to outperform market forecasts.&nbsp;</p><h2 class="st-heading-2">Albertsons Faces Multiple Analyst Downgrades</h2><p><a href="https://stocktwits.com/symbol/ACI">Albertsons Companies stock</a> faced three analyst downgrades this week after its fiscal second-quarter results, as concerns grew over its business plan and financial outlook.</p><p>JPMorgan lowered its rating to ‘Neutral’ from ‘Overweight’ but kept its $14 price target unchanged. Although Albertsons shares are cheaper than those of many U.S. grocery rivals, the firm believes ongoing business challenges and weaker-than-expected cost-cutting efforts may explain the lower valuation.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261016_044948856_fe781ba6d5.png" alt="koyfin_20261016_044948856.png" width="2400" height="1240"></figure><p>Goldman Sachs and Bank of America downgraded Albertsons and cut their price targets, citing uncertainty about the company’s growth plans and a suspended 2026 forecast. The analysts expect the stock to remain in a narrow range until management provides more details on its growth plans after completing a business review by spring 2027.</p><h2 class="st-heading-2">SpaceX Competition Clouds AT&amp;T,&nbsp; AST SpaceMobile Prospects</h2><p><a href="https://stocktwits.com/symbol/T">AT&amp;T stock</a> was downgraded to ‘Market Perform’ from ‘Outperform’ by Bernstein, which lowered its price target to $24 from $25. The analyst sees growing competition from SpaceX across broadband and wireless services as an additional challenge for established telecom providers.</p><p>Bernstein also cited recent pricing decisions by incumbent carriers and the possibility of seasonal weakness in the fourth quarter.&nbsp;<a href="https://stocktwits.com/symbol/ASTS">AST SpaceMobile stock</a> was downgraded to ‘Neutral’ from ‘Overweight’ at Piper Sandler, which cut its price target to $54 from $98. The firm has less confidence in the company's planned satellite deployment pace in 2026 and 2027.</p><p>SpaceX’s $8 billion purchase of mobile spectrum last week has raised concerns about competition in satellite-based phone services. Piper warned that SpaceX could limit rocket launch access for partners like AST SpaceMobile, delaying the company’s satellite deployment plans.&nbsp;</p><p>So far this year, CROX and LQDA have gained 0.8% and 45%, respectively, while ARRY, ACI, T and ASTS stocks have declined between 5% and 61%.&nbsp;</p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aa-stock-rises-overnight-alcoa-ceo-bets-on-massena-east-for-cash-pump-as-alumina-market-tightens/cZx0w5uRBs2">AA Stock Rises Overnight: Alcoa CEO Bets On Massena East For Cash Pump As Alumina Market Tightens</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

A Crocs logo sign is seen in New York City, United States.

Wall Street analysts warmed to Crocs Inc. (CROX) and Liquidia Corp. (LQDA) on growth potential and easing legal risks, while Albertsons Companies (ACI) faced downgrades from three firms. Meanwhile, SpaceX’s growing ambitions rattled sentiment around AT&T 

Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure

Albertsons Companies Inc - Ordinary Shares - Class A

Array Technologies Inc

AST SpaceMobile Inc

Crocs Inc

SpaceX

AT&T Inc

United Therapeutics Corp

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$34.13
Prev Close	$34.35
Open	$34.42
Dividend Yield	0.00%
50-Day Moving Average	$59.40
Beta	0.95
Avg. Volume	2.28M
PE Ratio	25.02

52-Week High	$93.61
52-Week Low	$21.94
Market Capitalization	$3.07B
EPS (Annual)	-$0.8009
Price to Book	15.59
Revenue Per Employee	$732,962.96

Feed

News

Sentiment

Earnings

Fundamentals

Info

LQDA Fundamentals